Clinical End-Points Associated with <i>Mycobacterium
tuberculosis</i> and Lung Cancer: Implications into Host-Pathogen Interaction and Coevolution

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Covariable name</td><td align="center">Frequency (%)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Category</td><td align="center">98.6</td></tr><tr><td align="left">Gender</td><td align="center">39.6</td></tr><tr><td align="left">Pathology grade</td><td align="center">62.1</td></tr><tr><td align="left">Lymph node metastasis</td><td align="center">93.9</td></tr><tr><td align="left">Tumor size</td><td align="center">65.8</td></tr><tr><td align="left">Clinical stage</td><td align="center">54.3</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Feature frequency table of generalized linear model.

BioMed Research International

tab4

Table 4

Table 4: Clinical End-Points Associated with <i>Mycobacterium
tuberculosis</i> and Lung Cancer: Implications into Host-Pathogen Interaction and Coevolution 

Table 4 | Clinical End-Points Associated with Mycobacterium
tuberculosis and Lung Cancer: Implications into Host-Pathogen Interaction and Coevolution 

BioMed Research International

Clinical End-Points Associated with Mycobacterium tuberculosis and Lung Cancer: Implications into Host-Pathogen Interaction and Coevolution

Table 4